X-100296462-C-T

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_001184880.2(PCDH19):​c.3262G>A​(p.Ala1088Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000744 in 1,209,093 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 25 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000081 ( 0 hom., 2 hem., cov: 22)
Exomes 𝑓: 0.000074 ( 0 hom. 23 hem. )

Consequence

PCDH19
NM_001184880.2 missense

Scores

1
3
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 3.26
Variant links:
Genes affected
PCDH19 (HGNC:14270): (protocadherin 19) The protein encoded by this gene is a member of the delta-2 protocadherin subclass of the cadherin superfamily. The encoded protein is thought to be a calcium-dependent cell-adhesion protein that is primarily expressed in the brain. Mutations in this gene on human chromosome X are associated with sporadic infantile epileptic encephalopathy and to a female-restricted form of epilepsy (EFMR; also known as PCDH19RE). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.19779503).
BP6
Variant X-100296462-C-T is Benign according to our data. Variant chrX-100296462-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 206306.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=2}. Variant chrX-100296462-C-T is described in Lovd as [Likely_benign].
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PCDH19NM_001184880.2 linkuse as main transcriptc.3262G>A p.Ala1088Thr missense_variant 6/6 ENST00000373034.8 NP_001171809.1 Q8TAB3-1
PCDH19NM_001105243.2 linkuse as main transcriptc.3121G>A p.Ala1041Thr missense_variant 5/5 NP_001098713.1 Q8TAB3-2B3KU71
PCDH19NM_020766.3 linkuse as main transcriptc.3118G>A p.Ala1040Thr missense_variant 5/5 NP_065817.2 Q8TAB3-3B3KU71

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PCDH19ENST00000373034.8 linkuse as main transcriptc.3262G>A p.Ala1088Thr missense_variant 6/61 NM_001184880.2 ENSP00000362125.4 Q8TAB3-1
PCDH19ENST00000255531.8 linkuse as main transcriptc.3121G>A p.Ala1041Thr missense_variant 5/51 ENSP00000255531.7 Q8TAB3-2
PCDH19ENST00000420881.6 linkuse as main transcriptc.3118G>A p.Ala1040Thr missense_variant 5/51 ENSP00000400327.2 Q8TAB3-3

Frequencies

GnomAD3 genomes
AF:
0.0000811
AC:
9
AN:
110946
Hom.:
0
Cov.:
22
AF XY:
0.0000603
AC XY:
2
AN XY:
33166
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000955
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.000671
GnomAD3 exomes
AF:
0.0000496
AC:
9
AN:
181434
Hom.:
0
AF XY:
0.0000742
AC XY:
5
AN XY:
67416
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000985
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000738
AC:
81
AN:
1098147
Hom.:
0
Cov.:
30
AF XY:
0.0000633
AC XY:
23
AN XY:
363505
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000284
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000938
Gnomad4 OTH exome
AF:
0.0000217
GnomAD4 genome
AF:
0.0000811
AC:
9
AN:
110946
Hom.:
0
Cov.:
22
AF XY:
0.0000603
AC XY:
2
AN XY:
33166
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000955
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000132
Gnomad4 OTH
AF:
0.000671
Alfa
AF:
0.000130
Hom.:
1
Bravo
AF:
0.0000680
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000305
AC:
2
ExAC
AF:
0.0000496
AC:
6
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAthena DiagnosticsApr 27, 2017- -
Developmental and epileptic encephalopathy, 9 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpNov 24, 2023This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 1088 of the PCDH19 protein (p.Ala1088Thr). This variant is present in population databases (rs370078729, gnomAD 0.009%). This missense change has been observed in individual(s) with clinical features of developmental and epileptic encephalopathy (Invitae). ClinVar contains an entry for this variant (Variation ID: 206306). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PCDH19 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsAug 08, 2022This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxNov 18, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
18
DANN
Uncertain
0.98
DEOGEN2
Benign
0.036
.;T;.
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.85
T;T;T
M_CAP
Pathogenic
0.50
D
MetaRNN
Benign
0.20
T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.0
.;N;.
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-0.43
N;N;N
REVEL
Benign
0.063
Sift
Uncertain
0.013
D;D;D
Sift4G
Benign
0.21
T;T;T
Polyphen
0.0010, 0.065
.;B;B
Vest4
0.38
MVP
0.45
MPC
0.50
ClinPred
0.10
T
GERP RS
4.1
Varity_R
0.15
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs370078729; hg19: chrX-99551460; API